Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: Prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy

Heart

Volumn 97, Issue 9, 2011, Pages 727-732

  Lehrke, Stephanie ^a   Lossnitzer, Dirk ^a   Schöb, Michael ^a   Steen, Henning ^a   Merten, Constanze ^a   Kemmling, Helmut ^a   Pribe, Regina ^a   Ehlermann, Philipp ^a   Zugck, Christian ^a   Korosoglou, Grigorios ^a   Giannitsis, Evangelos ^a   Katus, Hugo A ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CARDIOVASCULAR NUCLEAR MAGNETIC RESONANCE IMAGING; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEFIBRILLATION; FEMALE; FUNCTIONAL DISEASE; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; COHORT STUDIES; CONTRAST MEDIA; DEATH, SUDDEN, CARDIAC; FEMALE; GADOLINIUM; GADOLINIUM DTPA; HEART FAILURE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PROGNOSIS;

EID: 79953855307     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.205542     Document Type: Article

References (31)

1. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies. An American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 2006;113:1807-16. (Pubitemid 43958474)
2. Coughlin SS, Neaton JD, Sengupta A, et al. Predictors of mortality from idiopathic dilated cardiomyopathy in 356,222 men screened for the multiple risk factor intervention trial. Am J Epidemiol 1994;139:166-72. (Pubitemid 24045238)
3. Adams KF, Dunlap SH, Sueta CA, et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996;28:1781-8. (Pubitemid 26426235)
4. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077-84. (Pubitemid 30207690)
5. Michels VV, Driscoll DJ, Miller FA, et al. Progression of familial and non-familial dilated cardiomyopathy: long-term follow-up. Heart 2003;89:757-61. (Pubitemid 36760636)
6. Hombach V, Merkle N, Torzewski J, et al. Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy. Eur Heart J 2009;30:2011-18.
7. Miller WL, Hartman KA, Burritt MF, et al. Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies. Clin Cardiol 2007;30:245-50. (Pubitemid 46802326)
8. Pennell D. Cardiovascular magnetic resonance. Heart 2001;85:581-9. (Pubitemid 32973509)
9. McCrohon JA, Moon JCC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium- enhanced magnetic resonance. Circulation 2003;108:54-9. (Pubitemid 36859020)
10. Wu KC, Weiss RG, Thiemann DR, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. Circulation 2003;108:54-9
11. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-85. (Pubitemid 44738448)
12. O'Hanlon R, Grasso A, Roughton M, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:867-74.
13. Bruder O, Wagner A, Jensen CJ, et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:875-87.
14. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996;93:841-2. (Pubitemid 26074816)
15. Unverferth DV, Baker PB, Swift SE, et al. Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol 1986;57:816-20. (Pubitemid 16054340)
16. Waller TA, Hiser WL, Capehart JE, et al. Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy and dilated hypertrophic cardiomyopathy. Am J Cardiol 1998;81:884-94. (Pubitemid 28213993)
17. Baig MK, Mahon N, McKenna WJ, et al. The pathophysiology of advanced heart failure. Am Heart J 1998;135:216-30.
18. De Leeuw N, Ruiter DJ, Balk AHMM, et al. Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int 2001;14:299-306. (Pubitemid 33021059)
19. Schalla S, Bekkers SC, Dennert R, et al. Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy. Eur J Heart Fail 2010;12:227-31.
20. Beltrami CA, Finato N, Rocco M, et al. The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol 1995;27:291-305.
21. Ryoke T, Gu Y, Mao L, et al. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensindconverting enzyme inhibition. Circulation 1999;100:1734-43. (Pubitemid 29485257)
22. Heling A, Zimmermann R, Kostin S, et al. Increased expression of cytoskeletal, linkage and extracellular proteins in failing human myocardium. Circ Res 2000;86:846-53. (Pubitemid 30246981)
23. Bello D, Fieno DS, Kim RJ, et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 2005;45:1104-8. (Pubitemid 40432446)
24. Nazarian S, Bluemke DA, Lardo AC, et al. Magnetic resonance assessement of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005;112:2821-5. (Pubitemid 41641676)
25. Choi EY, Choi BW, Kim SA, et al. Patterns of late gadolinium enhancement are associated with ventricular stiffness in patients with advanced non-ischaemic dilated cardiomyopathy. Eur J Heart Fail 2009;11:573-80.
26. Mahrholdt H, Wagner A, Deluigi CC, et al. Presentation, patterns of myocardial damage and clinical course of viral myocarditis. Circulation 2006;114:1581-90. (Pubitemid 44547428)
27. Raman SV, Sparks EA, Baker PM, et al. Mid-myocardial fibrosis by cardiac magnetic resonance in patients with lamin A/C cardiomyopathy: possible substrate for diastolic dysfunction. J Cardiovasc Magn Reson 2007;9:907-13. (Pubitemid 350232927)
28. Messroghli DR, Plein S, Higgins DM, et al. Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution- reproducibility study. Radiology 2005;238:1004-12.
29. Jerosch- Herold M, Sheridan DC, Kushner JD, et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2008;295:1234-42.
30. Iles L, Pfluger H, Phrommintikul A, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008;52:1574-80.
31. Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006;113:671-78.